Quest Diagnostics to Present Innovative Healthcare Insights at Leerink Conference 2026

Quest Diagnostics Amplifies Healthcare Insights at Leerink Global Conference

Quest Diagnostics Incorporated, a frontline leader in diagnostic information services, is gearing up for a significant presentation at the upcoming Leerink 2026 Global Healthcare Conference. Scheduled for March 11, 2026, Executive Vice President and Chief Financial Officer Sam Samad will navigate through the company's strategic directions and current developments in the healthcare market during a Fireside Chat session. The discussion promises to delve into Quest’s commitment to innovation and its role as a critical player in enhancing healthcare outcomes through better diagnostic solutions. Attendees can access the live stream on the company's investor relations website, with a replay available for those unable to attend in real-time.

Quest Diagnostics' strategic focus centers on fostering improved health outcomes for a vast population, as it serves approximately half of physicians and hospitals across the United States. With an expansive reach, the company connects with one in three American adults each year, underlining its essential role in the healthcare ecosystem. By prioritizing intelligent and user-friendly testing solutions, Quest Diagnostics aims to furnish clinicians with vital laboratory insights that can drive informed decision-making and promote healthier behaviors among patients. This commitment is distilled into the company’s mission to transform lives through actionable diagnostic insights.

Moreover, Quest Diagnostics continues to reinforce its dedication to innovation in healthcare management. Recent announcements highlight their proactive approach, including the release of their financial results for the fourth quarter and full year of 2025, coupled with a 7.5% increase in their quarterly dividend. These advancements signal the company's robust position in the healthcare landscape and aim to further empower clinicians and patients by identifying diseases through advanced testing and diagnostics. As Quest Diagnostics navigates market developments, its focus remains steadfast on improving disease detection and treatment methodologies, ultimately enhancing overall healthcare management.

In addition to its engaging presentations, Quest Diagnostics actively works to keep the public informed about its initiatives and advancements. With nearly 57,000 employees dedicated to delivering high-quality diagnostic insights, the company is positioned not only as a service provider but also as a leader in public health advocacy. For continued updates and further information on its services and strategic goals, stakeholders and interested parties can visit their website at www.QuestDiagnostics.com.